Japan Blood And Blood Forming Organs Medicine Sales is set to reach $6,690 Million by 2026 from $5,930 Million, is expected to rise 8.7% per year. Since 2017, the market increased 6.1% year on year to $27,250 Million. Germany, Italy and South Korea respectively came in numbers 2, 3 and 4 in this ranking.
How does Japan perform in Blood Disease?
Forecast: Blood and Blood Forming Organs Medicine Sales in Japan
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research
Forecast: Blood and Blood Forming Organs Medicine Sales in Japan
- US Dollars PPP Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Blood and Blood Forming Organs Medicine Sales in Japan
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Blood and Blood Forming Organs Medicine Sales in Japan
- Million Japanese Yens
- 2024 to 2028
- ReportLinker Research
Forecast: Blood and Blood Forming Organs Medicine Sales in Japan
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Forecast: Prevalence of Anemia in Japan
- Percent of Children Under 5
- 2024 to 2028
- ReportLinker Research
Forecast: Prevalence of Anemia in Japan
- Percent of Women Aged 15-49
- 2024 to 2028
- ReportLinker Research
Forecast: Anemia Prevalence Among Pregnant Women in Japan
- Percent
- 2024 to 2028
- ReportLinker Research
Forecast: Anaemia Prevalence in Japan
- Percent of Children Under 5
- 2024 to 2028
- ReportLinker Research
Forecast: Anaemia Prevalence in Japan
- Percent of Non-Pregnant Women
- 2024 to 2028
- ReportLinker Research